Emerging DPP-4 Inhibitors: Focus on Linagliptin for Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand
doi 10.2147/dmso.s23166
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited